1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Antimicrobial Resistance Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Antimicrobial Resistance Diagnostics Market, by Technology
8.1.1. Phenotypic AMR Diagnostics
8.1.1.1. Market Revenue and Forecast
8.1.2. Molecular AMR Diagnostics
8.1.2.1. Market Revenue and Forecast
8.1.3. Others (MALDI-TOF, Microarrays)
8.1.3.1. Market Revenue and Forecast
9.1. Antimicrobial Resistance Diagnostics Market, by Test Type
9.1.1. Antimicrobial Susceptibility Testing (AST)
9.1.1.1. Market Revenue and Forecast
9.1.2. Resistance Gene Detection
9.1.2.1. Market Revenue and Forecast
9.1.3. Pathogen Identification with AMR Profiling
9.1.3.1. Market Revenue and Forecast
10.1. Antimicrobial Resistance Diagnostics Market, by Sample Type
10.1.1. Blood & Plasma Samples
10.1.1.1. Market Revenue and Forecast
10.1.2. Urine Samples
10.1.2.1. Market Revenue and Forecast
10.1.3. Respiratory Samples
10.1.3.1. Market Revenue and Forecast
10.1.4. Wound/Tissue Samples
10.1.4.1. Market Revenue and Forecast
10.1.5. Other Samples (CSF, stool)
10.1.5.1. Market Revenue and Forecast
11.1. Antimicrobial Resistance Diagnostics Market, by Application
11.1.1. Clinical Diagnostics
11.1.1.1. Market Revenue and Forecast
11.1.2. Veterinary Diagnostics
11.1.2.1. Market Revenue and Forecast
11.1.3. Food & Feed Safety Testing
11.1.3.1. Market Revenue and Forecast
11.1.4. Environmental Surveillance
11.1.4.1. Market Revenue and Forecast
12.1. Antimicrobial Resistance Diagnostics Market, by End-User
12.1.1. Hospitals & Clinical Laboratories
12.1.1.1. Market Revenue and Forecast
12.1.2. Reference & Specialized Laboratories
12.1.2.1. Market Revenue and Forecast
12.1.3. Veterinary Clinics & Labs
12.1.3.1. Market Revenue and Forecast
12.1.4. Public Health & Research Institutes
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology
13.1.2. Market Revenue and Forecast, by Test Type
13.1.3. Market Revenue and Forecast, by Sample Type
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology
13.1.6.2. Market Revenue and Forecast, by Test Type
13.1.6.3. Market Revenue and Forecast, by Sample Type
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology
13.1.7.2. Market Revenue and Forecast, by Test Type
13.1.7.3. Market Revenue and Forecast, by Sample Type
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology
13.2.2. Market Revenue and Forecast, by Test Type
13.2.3. Market Revenue and Forecast, by Sample Type
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology
13.2.6.2. Market Revenue and Forecast, by Test Type
13.2.6.3. Market Revenue and Forecast, by Sample Type
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology
13.2.9.2. Market Revenue and Forecast, by Test Type
13.2.9.3. Market Revenue and Forecast, by Sample Type
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology
13.2.12.2. Market Revenue and Forecast, by Test Type
13.2.12.3. Market Revenue and Forecast, by Sample Type
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology
13.2.14.2. Market Revenue and Forecast, by Test Type
13.2.14.3. Market Revenue and Forecast, by Sample Type
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology
13.3.2. Market Revenue and Forecast, by Test Type
13.3.3. Market Revenue and Forecast, by Sample Type
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology
13.3.6.2. Market Revenue and Forecast, by Test Type
13.3.6.3. Market Revenue and Forecast, by Sample Type
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology
13.3.8.2. Market Revenue and Forecast, by Test Type
13.3.8.3. Market Revenue and Forecast, by Sample Type
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology
13.3.10.2. Market Revenue and Forecast, by Test Type
13.3.10.3. Market Revenue and Forecast, by Sample Type
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology
13.3.11.2. Market Revenue and Forecast, by Test Type
13.3.11.3. Market Revenue and Forecast, by Sample Type
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology
13.4.2. Market Revenue and Forecast, by Test Type
13.4.3. Market Revenue and Forecast, by Sample Type
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology
13.4.6.2. Market Revenue and Forecast, by Test Type
13.4.6.3. Market Revenue and Forecast, by Sample Type
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology
13.4.8.2. Market Revenue and Forecast, by Test Type
13.4.8.3. Market Revenue and Forecast, by Sample Type
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology
13.4.10.2. Market Revenue and Forecast, by Test Type
13.4.10.3. Market Revenue and Forecast, by Sample Type
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology
13.4.11.2. Market Revenue and Forecast, by Test Type
13.4.11.3. Market Revenue and Forecast, by Sample Type
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology
13.5.2. Market Revenue and Forecast, by Test Type
13.5.3. Market Revenue and Forecast, by Sample Type
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology
13.5.6.2. Market Revenue and Forecast, by Test Type
13.5.6.3. Market Revenue and Forecast, by Sample Type
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology
13.5.8.2. Market Revenue and Forecast, by Test Type
13.5.8.3. Market Revenue and Forecast, by Sample Type
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. BD
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BIOMERIEUX
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Abbott
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Accelerate Diagnostics, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Danaher
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Hologic Inc. (Gen Probe)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Molsid
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. F. Hoffmann-La Roche, Ltd.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Vela Diagnostics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Visby Medical, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
